Stay updated on M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page.

Latest updates to the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check7 days agoChange DetectedThe participating locations list has been updated with additions and removals across multiple sites and countries.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded: Show glossary feature; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page shows a minor revision note: Revision: v3.3.4 replaces v3.3.3, with no substantive changes to study details, enrollment, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedNo substantive changes detected to the Study Details page; core information such as study design, eligibility criteria, endpoints, and locations remains the same.SummaryDifference0.1%

- Check36 days agoChange DetectedNo significant additions or deletions were detected on the page; core study details and eligibility information appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page.